MicroRNA expression signatures of stage, grade, and progression in clear cell RCC

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11 - 30; http://dx.doi.org/10.3322/caac.21166; PMID: 23335087
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 2002; 20:2376 - 81; http://dx.doi.org/10.1200/JCO.2002.11.123; PMID: 11981011
   PubMed Web of Science ®Google Scholar
• Banumathy G, Cairns P. Signaling pathways in renal cell carcinoma. Cancer Biol Ther 2010; 10:658 - 64; http://dx.doi.org/10.4161/cbt.10.7.13247; PMID: 20814228
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759 - 67; http://dx.doi.org/10.1016/0092-8674(90)90186-I; PMID: 2188735
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57 - 70; http://dx.doi.org/10.1016/S0092-8674(00)81683-9; PMID: 10647931
   PubMed Web of Science ®Google Scholar
• Cairns P. Renal cell carcinoma. Cancer Biomark 2010; 9:461 - 73; PMID: 22112490
   PubMed Web of Science ®Google Scholar
• Lam JS, Klatte T, Kim HL, Patard JJ, Breda A, Zisman A, Pantuck AJ, Figlin RA. Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol 2008; 65:235 - 62; http://dx.doi.org/10.1016/j.critrevonc.2007.08.003; PMID: 17931881
   PubMed Web of Science ®Google Scholar
• Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 2013; 14:159 - 67; http://dx.doi.org/10.1016/S1470-2045(12)70584-3; PMID: 23333114
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92 - 105; http://dx.doi.org/10.1101/gr.082701.108; PMID: 18955434
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857 - 66; http://dx.doi.org/10.1038/nrc1997; PMID: 17060945
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259 - 69; http://dx.doi.org/10.1038/nrc1840; PMID: 16557279
   PubMed Web of Science ®Google Scholar
• Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179; http://dx.doi.org/10.1093/nar/gni178; PMID: 16314309
   PubMed Web of Science ®Google Scholar
• Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer 2008; 113:450 - 60; http://dx.doi.org/10.1002/cncr.23566; PMID: 18523999
   PubMed Web of Science ®Google Scholar
• Atlas CG, Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499:43 - 9; http://dx.doi.org/10.1038/nature12222; PMID: 23792563
   PubMed Web of Science ®Google Scholar
• Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA, et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009; 69:4674 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-09-0146; PMID: 19470766
   PubMed Web of Science ®Google Scholar
• Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, et al. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 2012; 14:385 - 92; http://dx.doi.org/10.1016/j.jmoldx.2012.02.003; PMID: 22580180
   PubMed Web of Science ®Google Scholar
• Spizzo R, Nicoloso MS, Croce CM, Calin GA. SnapShot: MicroRNAs in Cancer. Cell 2009; 137:586 - e1; http://dx.doi.org/10.1016/j.cell.2009.04.040; PMID: 19410551
   PubMed Web of Science ®Google Scholar
• Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D’Esposito M, Di Lauro R, Verde P. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009; 28:73 - 84; http://dx.doi.org/10.1038/onc.2008.370; PMID: 18850008
   PubMed Web of Science ®Google Scholar
• Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008; 68:8164 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-08-1305; PMID: 18829576
   PubMed Web of Science ®Google Scholar
• Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev 2009; 23:2152 - 65; http://dx.doi.org/10.1101/gad.1820109; PMID: 19759263
   PubMed Web of Science ®Google Scholar
• Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS. Identification of a microRNA panel for clear-cell kidney cancer. Urology 2010; 75:835 - 41; http://dx.doi.org/10.1016/j.urology.2009.10.033; PMID: 20035975
   PubMed Web of Science ®Google Scholar
• Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H. Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing. PLoS One 2012; 7:e38298; http://dx.doi.org/10.1371/journal.pone.0038298; PMID: 22745662
   PubMed Web of Science ®Google Scholar
• Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang H, Hong M, Jiang T, Jiang Q, Lu J, et al. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia 2012; 26:769 - 77; http://dx.doi.org/10.1038/leu.2011.273; PMID: 21979877
   PubMed Web of Science ®Google Scholar
• Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J Clin Invest 2010; 120:4141 - 54; http://dx.doi.org/10.1172/JCI42980; PMID: 20972335
   PubMed Web of Science ®Google Scholar
• Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010; 17:F19 - 36; http://dx.doi.org/10.1677/ERC-09-0184; PMID: 19779035
   PubMed Web of Science ®Google Scholar
• Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482:347 - 55; http://dx.doi.org/10.1038/nature10888; PMID: 22337054
   PubMed Web of Science ®Google Scholar
• Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007; 101:59 - 68; http://dx.doi.org/10.1161/CIRCRESAHA.107.153916; PMID: 17540974
   PubMed Web of Science ®Google Scholar
• Wang H, Ach RA, Curry B. Direct and sensitive miRNA profiling from low-input total RNA. RNA 2007; 13:151 - 9; http://dx.doi.org/10.1261/rna.234507; PMID: 17105992
   PubMed Web of Science ®Google Scholar
• Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach H, et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 2009; 13:9B 3918 - 28; http://dx.doi.org/10.1111/j.1582-4934.2009.00705.x; PMID: 19228262
   PubMed Web of Science ®Google Scholar
• Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012; 21:532 - 46; http://dx.doi.org/10.1016/j.ccr.2012.02.019; PMID: 22516261
   PubMed Web of Science ®Google Scholar
• Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, Li W, Hu B, Cheng SY, Li M. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res 2013; 73:990 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-12-2895; PMID: 23204229
   PubMed Web of Science ®Google Scholar
• Zou C, Xu Q, Mao F, Li D, Bian C, Liu LZ, Jiang Y, Chen X, Qi Y, Zhang X, et al. MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle 2012; 11:2137 - 45; http://dx.doi.org/10.4161/cc.20598; PMID: 22592534
   PubMed Web of Science ®Google Scholar
• Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients. Genes Chromosomes Cancer 2012; 51:707 - 16; http://dx.doi.org/10.1002/gcc.21957; PMID: 22492545
   PubMed Web of Science ®Google Scholar
• Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer 2012; 130:2044 - 53; http://dx.doi.org/10.1002/ijc.26218; PMID: 21633953
   PubMed Web of Science ®Google Scholar
• Sun L, Xie H, Mori MA, Alexander R, Yuan B, Hattangadi SM, Liu Q, Kahn CR, Lodish HF. Mir193b-365 is essential for brown fat differentiation. Nat Cell Biol 2011; 13:958 - 65; http://dx.doi.org/10.1038/ncb2286; PMID: 21743466
   PubMed Web of Science ®Google Scholar
• Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C, Jensen RV, Moskaluk CA, Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011; 71:1313 - 24; http://dx.doi.org/10.1158/0008-5472.CAN-10-1031; PMID: 21212412
   PubMed Web of Science ®Google Scholar
• Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K, Dalamagas T, Hatzigeorgiou AG. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 2012; 40:W498-504; http://dx.doi.org/10.1093/nar/gks494; PMID: 22649059
   PubMedGoogle Scholar
• Weng L, Wu X, Gao H, Mu B, Li X, Wang JH, Guo C, Jin JM, Chen Z, Covarrubias M, et al. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 2010; 222:41 - 51; PMID: 20593407
   PubMed Web of Science ®Google Scholar
• Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, et al. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 2012; 7:e35661; http://dx.doi.org/10.1371/journal.pone.0035661; PMID: 22623952
   PubMed Web of Science ®Google Scholar
• Liu Y, Lai L, Chen Q, Song Y, Xu S, Ma F, Wang X, Wang J, Yu H, Cao X, et al. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol 2012; 188:5500 - 10; http://dx.doi.org/10.4049/jimmunol.1103505; PMID: 22544933
   PubMed Web of Science ®Google Scholar
• Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q, Zhao RC. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 2012; 21:2531 - 40; http://dx.doi.org/10.1089/scd.2012.0014; PMID: 22375943
   PubMed Web of Science ®Google Scholar
• Bar N, Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010; 5:e10859; http://dx.doi.org/10.1371/journal.pone.0010859; PMID: 20523723
   PubMedGoogle Scholar
• Yin G, Alvero AB, Craveiro V, Holmberg JC, Fu HH, Montagna MK, Yang Y, Chefetz-Menaker I, Nuti S, Rossi M, et al. Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 2013; 32:39 - 49; http://dx.doi.org/10.1038/onc.2012.33; PMID: 22349827
   PubMed Web of Science ®Google Scholar
• Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, et al. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 2008; 216:418 - 27; http://dx.doi.org/10.1002/path.2437; PMID: 18925646
   PubMed Web of Science ®Google Scholar
• White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br J Cancer 2011; 105:1741 - 9; http://dx.doi.org/10.1038/bjc.2011.401; PMID: 22033272
   PubMed Web of Science ®Google Scholar
• Morrogh M, Olvera N, Bogomolniy F, Borgen PI, King TA. Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue. Biotechniques 2007; 43:41 - 2, 44, 46 passim; http://dx.doi.org/10.2144/000112497; PMID: 17695251
   PubMed Web of Science ®Google Scholar
• Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol 2002; 167:57 - 60; http://dx.doi.org/10.1016/S0022-5347(05)65382-7; PMID: 11743275
   PubMed Web of Science ®Google Scholar
• Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P, Caldas C. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010; 16:991 - 1006; http://dx.doi.org/10.1261/rna.1947110; PMID: 20360395
   PubMed Web of Science ®Google Scholar
• Pradervand S, Weber J, Lemoine F, Consales F, Paillusson A, Dupasquier M, Thomas J, Richter H, Kaessmann H, Beaudoing E, et al. Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. Biotechniques 2010; 48:219 - 22; http://dx.doi.org/10.2144/000113367; PMID: 20359303
   PubMed Web of Science ®Google Scholar
• Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6:655 - 63; http://dx.doi.org/10.1097/00000478-198210000-00007; PMID: 7180965
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III. Chapter 43 Kidney. AJCC Cancer Staging Manual Seventh Edition 2009:479-90
   Google Scholar
• Tissot C. Analysis of miRNA content in total RNA preparations using the Agilent 2100 bioanalyzer. Agilent Technologies Application Note 2008; Publication Number 5989-7870EN. Available from: http://www.chem.agilent.com/Library/applications/5989-7870EN.pdf
   Google Scholar
• Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:e3; http://dx.doi.org/10.2202/1544-6115.1027; PMID: 16646809
   PubMedGoogle Scholar